MURRIETA, Calif. , Sept. 24, 2025 /PRNewswire/ -- Copan Diagnostics , part of the privately held Italy -based Copan Group and a leader in specimen collection and transport, and laboratory automation, announced over $7 million in new U.S. manufacturing investments in California and Puerto Rico . This expansion underscores Copan's commitment to serving the U.S. market with locally manufactured products.

The investment includes facility expansions, new manufacturing processes, advanced quality control systems, and implementation of new production technologies in the U.S. This initiative accelerates production of critical components and finished goods, such as UTM® Universal Transport Medium kits , used for collecting respiratory viral specimens , and UriSponge®

See Full Page